adriamycinol has been researched along with 23-hydroxybetulinic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, G; Hao, K; Luo, D; Niu, F; Sun, Y; Wang, G; Wu, L; Wu, X; Ye, W; Zhang, J; Zheng, Y; Zhou, F | 1 |
1 other study(ies) available for adriamycinol and 23-hydroxybetulinic acid
| Article | Year |
|---|---|
Protective effect of 23-hydroxybetulinic acid on doxorubicin-induced cardiotoxicity: a correlation with the inhibition of carbonyl reductase-mediated metabolism.
Topics: Alcohol Oxidoreductases; Animals; Apoptosis; Cardiotoxicity; Cell Proliferation; Cell Survival; Cells, Cultured; Cytoprotection; Dose-Response Relationship, Drug; Doxorubicin; Enzyme Inhibitors; Male; Mice; Mice, Inbred BALB C; Molecular Docking Simulation; Rats; Structure-Activity Relationship; Triterpenes | 2015 |